DonaldECutlipMD
Cardiology • Boston, MAInterventional Cardiology
Professor of Medicine, Beth Israel Deaconess Medical Center
Dr. Cutlip is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Beth Israel Deaconess Med Ctr
330 Brookline Ave Es217
Boston, MA 02215Phone+1 617-667-7455Fax+1 617-632-7460
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1992 - 1996
University of ConnecticutResidency, Internal Medicine, 1979 - 1983
University of South Florida College of MedicineClass of 1979
Certifications & Licensure
MA State Medical License 1993 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions Start of enrollment: 2004 Apr 01
- Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization. Start of enrollment: 2007 Jan 01
- EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events Start of enrollment: 2010 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP...Sheldon E Litwin, Jan Komtebedde, Barry A Borlaug, David M Kaye, Gerd Hasenfuβ
American Heart Journal. 2024-12-01 - Randomized Trial of COBRA PzF Stenting to Reduce the Duration of Triple Therapy: The COBRA-REDUCE Trial.Robert A Byrne, Róisín Colleran, J J Coughlan, Rajiv Jauhar, Luc Maillard
Circulation. Cardiovascular Interventions. 2024-10-01 - 1 citations2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II.Finn Gustafsson, Mark C Petrie, Jan Komtebedde, Vijendra Swarup, Sebastian Winkler
JACC. Heart Failure. 2024-08-01
Journal Articles
- Original Investigations Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents: BIOFLOW V 2-Year ResultsDavid E Kandzari, Ron Waksman, Donald E Cutlip, Elie G Gharib, ScienceDirect
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentWilliam F Fearon, John Spertus, Roxana Mehran, Donald Cutlip, Gregg W Stone, Mitchell W Krucoff, European Heart Journal
Authored Content
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Press Mentions
New Biomarker-Based Risk Score Performs Well in ACSOctober 25th, 2022- Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?December 2nd, 2020
- Making Sense of MI: EXCEL and SYNTAX Tackle Event DefinitionsSeptember 28th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
